AngioDynamics (ANGO)
AngioDynamics Key Statistics
Pro Data ExportCurrent Valuation
| Market Cap | 306.46M |
| Enterprise Value | 278.76M |
| PE Ratio | 406.67 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Sales Ratio | 1.391 |
| Price / Book Value | 0.745 |
| EV / Revenues Pro | Go Pro |
| EV / EBITDA Pro | Go Pro |
| EV / EBIT Pro | Go Pro |
| Operating Earnings Yield Pro | Go Pro |
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 57.04% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -3.43% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 7.229 |
| Debt to Equity Ratio | 0.0154 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -2.32% |
| Year to Date Stock Returns | -17.62% |
| 1 Year Stock Returns | -20.62% |
| 3 Year Stock Returns | -7.86% |
| 52 Week High | 16.39 |
| 52 Week Low | 11.35 |
Income Statement
| Revenues TTM | 220.32M |
| Revenue Per Share TTM | 8.771 |
| Revenue Growth | -5.64% |
| Gross Profit TTM | 127.22M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | 1.073M |
| Earnings Per Share TTM | 0.03 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -26.72M |
| Cash Financing TTM | 1.108M |
| Cash Operations TTM | 24.40M |
| Capital Expenditures | 0.821M |
Share Statistics
| Shares Outstanding | 25.12M |
Balance Sheet
| Cash and ST Investments | 143.03M |
| Total Assets | 446.61M |
| Liabilities | 35.24M |
| Book Value | 411.36M |
| Book Value per Share | 16.38 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 6.345M |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these ANGO related companies
ANGO News
AngioDynamics Completes Acquisition of Navilyst Medical http://stks.co/3vuI $ANGO
about 5 days ago by evcgroup
about 5 days ago by evcgroup
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition
http://stks.co/3qGr $ANGO
about 12 days ago by evcgroup
about 12 days ago by evcgroup
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition
May 15, 5:04PM GlobeNewswire
May 15, 5:04PM GlobeNewswire
RT @MedDevice ABC on Dr. Cunningham of @VeinClinics on the VenaCure 1470 for varicose veins bit.ly/VeinClinicsofAmericaBrentwood $ANGO
about 20 days ago by evcgroup
about 20 days ago by evcgroup
AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Apr 04, 8:50PM Seeking Alpha
Apr 04, 8:50PM Seeking Alpha
Listen to $ANGO Q3 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3E55
about 53 days ago by earningscast
about 53 days ago by earningscast
NanoKnife® System Clinical Experience Featured at Society of Surgical Oncology Conference
Apr 02, 6:30AM Business Wire
Apr 02, 6:30AM Business Wire
Canaccord Genuity Maintains a 'Buy' on AngioDynamics (ANGO); Q3 Preview
Mar 30, 8:40AM Street Insider
Mar 30, 8:40AM Street Insider
AngioDynamics Establishes Strategic Relationship with Microsulis Medical Ltd.
Mar 26, 6:40AM Benzinga
Mar 26, 6:40AM Benzinga
AngioDynamics (ANGO) Invests, Enters Distribution Agreement with Microsulis Medical
Mar 26, 6:36AM Street Insider
Mar 26, 6:36AM Street Insider
AngioDynamics to Report Fiscal 2012 Third Quarter Financial Results and Hold Conference Call on April 4, 2012
Mar 21, 6:30AM GlobeNewswire
Mar 21, 6:30AM GlobeNewswire
AngioDynamics Receives FDA Clearance for NeverTouch Direct Procedure Kit to be Used With VenaCure EVLT System
http://stks.co/2OQd $ANGO
about 103 days ago by evcgroup
about 103 days ago by evcgroup
AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter http://stks.co/2InF $ANGO
about 109 days ago by evcgroup
about 109 days ago by evcgroup
$ANGO 200 Day SMA Cross - Price crossed below 200 day SMA (14.4842). Confirmed by volume.
about 117 days ago by TradeIdeasQuant
about 117 days ago by TradeIdeasQuant
$ANGO Q3 adj-EPS from 9-11c to 7-9c, Q4 from 11-13c to 10-12c, FY12 from 41-45c to 38-42c
about 124 days ago by Street_Insider
about 124 days ago by Street_Insider
Listen to $ANGO Q2 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/1nIm
about 143 days ago by earningscast
about 143 days ago by earningscast
$ANGO Reports Q2 EPS $0.09 vs $0.12 Est; Revenues $58.10M vs $56.26M Est
about 143 days ago by Benzinga
about 143 days ago by Benzinga
AngioDynamics' new VenaCure 1470 in Houston http://stks.co/1PWW $ANGO
about 173 days ago by evcgroup
about 173 days ago by evcgroup
Listen to $ANGO at piper jaffray health care conference - live at 03:00 PM, ondemand after - http://stks.co/1KNG
about 179 days ago by earningscast
about 179 days ago by earningscast
AngioDynamics Expands Senior Leadership Team $ANGO http://stks.co/11Gy
about 201 days ago by evcgroup
about 201 days ago by evcgroup
RT @EVCGroup RT @MedDevice Here's where varicose vein treatment is today, a solid summary in Vascular Disease Management goo.gl/j3Vk1 $ANGO
about 205 days ago by evcgroup
about 205 days ago by evcgroup
$ANGO Reports Q1 EPS $0.08 vs $0.08 Est; Revenue $54.4M vs $53.86M Est; Announces Stock Repurchase Authorization of up to $20M
about 234 days ago by Benzinga
about 234 days ago by Benzinga
AngioDynamics $ANGO shares falling as FDA issues warning letter over NY plant inspection
about 271 days ago by Street_Insider
about 271 days ago by Street_Insider
After falling about 3% before the Nasdaq could halt, shares of $ANGO have bounced upon resumption, now down about 1.2% from today's close.
about 488 days ago by Street_Insider
about 488 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANGO | 12.20 | -0.13 | -1.05% | 306.46M |
| ANGN | 5.85 | +0.20 | +3.54% | 22.93M |
| ANF | 36.23 | +0.94 | +2.66% | 3.069B |
| ANEN | 19.05 | +0.06 | +0.32% | 283.65M |
| ASPS | 57.98 | -1.04 | -1.76% | 1.352B |
| ASP | 11.61 | -0.05 | -0.46% | |
| ASNA | 18.90 | -0.02 | -0.11% | 2.896B |
| ASML | 46.00 | -0.22 | -0.48% | 19.03B |
| ASMI | 35.28 | -0.28 | -0.79% | 1.954B |
| ASM | 1.24 | -0.01 | -0.72% | 25.52M |